BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24106949)

  • 1. Treatment of acute promyelocytic leukemia.
    Miura Y; Suyama K; Takano T
    N Engl J Med; 2013 Oct; 369(15):1471-2. PubMed ID: 24106949
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acute promyelocytic leukemia.
    Lo-Coco F; Orlando SM; Platzbecker U
    N Engl J Med; 2013 Oct; 369(15):1472. PubMed ID: 24106948
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting agents alone to cure acute promyelocytic leukemia.
    Chen SJ; Chen Z
    N Engl J Med; 2013 Jul; 369(2):186-7. PubMed ID: 23841735
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy-free treatment of acute promyelocytic leukemia.
    Ravandi F
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):498-500. PubMed ID: 26351810
    [No Abstract]   [Full Text] [Related]  

  • 5. Time to abandon traditional chemotherapy for acute promyelocytic leukaemia?
    Ravandi F; Kantarjian H
    Lancet Oncol; 2015 Oct; 16(13):1274-5. PubMed ID: 26384240
    [No Abstract]   [Full Text] [Related]  

  • 6. How health-related quality-of-life outcomes in patients with acute promyelocytic leukemia can help physicians in decision making.
    Koehler M; Fischer T
    J Clin Oncol; 2015 Mar; 33(9):1090-1. PubMed ID: 25691667
    [No Abstract]   [Full Text] [Related]  

  • 7. Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia.
    Young CS; Clarke KM; Mills KI
    EBioMedicine; 2015 Jun; 2(6):487-8. PubMed ID: 26288810
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to M. Koehler et al.
    Efficace F; Cottone F; Lo-Coco F
    J Clin Oncol; 2015 Mar; 33(9):1091-2. PubMed ID: 25691680
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia.
    Breccia M; Cicconi L; Minotti C; Latagliata R; Giannì L; Lo-Coco F
    Haematologica; 2011 Sep; 96(9):1390-1. PubMed ID: 21659361
    [No Abstract]   [Full Text] [Related]  

  • 10. Newly diagnosed acute promyelocytic leukemia: arsenic moves front and center.
    Estey EH; Hutchinson F
    J Clin Oncol; 2011 Jul; 29(20):2743-6. PubMed ID: 21646610
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arsenic treatment for leukemia: new model of human cancer target treatment].
    Zhao WW; Chen SJ
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):439-40. PubMed ID: 15854545
    [No Abstract]   [Full Text] [Related]  

  • 12. Arsenic and apoptosis in the treatment of acute promyelocytic leukemia.
    Look AT
    J Natl Cancer Inst; 1998 Jan; 90(2):86-8. PubMed ID: 9450562
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
    Sasaki M; Sugimoto K; Isobe Y; Oshimi K
    Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance to therapy in acute promyelocytic leukemia.
    Lehmann-Che J; Bally C; de Thé H
    N Engl J Med; 2014 Sep; 371(12):1170-2. PubMed ID: 25229938
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in management of acute promyelocytic leukemia with arsenic trioxide.
    Ma J
    Chin J Integr Med; 2007 Jun; 13(2):92-4. PubMed ID: 17609904
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy.
    Park JH; Tallman MS
    Oncology (Williston Park); 2011 Jul; 25(8):733-41. PubMed ID: 21874835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of an arsenic trioxide-based regimen over a historic control combining all-trans retinoic acid plus intensive chemotherapy in the treatment of relapsed acute promyelocytic leukemia.
    Thomas X; Pigneux A; Raffoux E; Huguet F; Caillot D; Fenaux P
    Haematologica; 2006 Jul; 91(7):996-7. PubMed ID: 16757416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute promyelocytic leukemia in children: arsenic or ATRA.
    Ravindranath Y; Gregory J; Feusner J
    Leukemia; 2004 Oct; 18(10):1576-7. PubMed ID: 15356650
    [No Abstract]   [Full Text] [Related]  

  • 19. Don't just stand there, do something: strategies for the prevention of early death in acute promyelocytic leukemia: a commentary.
    Tallman MS; Manji GA
    Blood Cells Mol Dis; 2011 Feb; 46(2):173-4. PubMed ID: 21227722
    [No Abstract]   [Full Text] [Related]  

  • 20. Hot on the TRAIL of acute promyelocytic leukemia.
    Zelent A
    Nat Med; 2001 Jun; 7(6):662-4. PubMed ID: 11385499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.